Speed, Quality & Cost – Why You Should Be Conducting Your Clinical Trials in Australia (WS22)
- Date:
- 29 April 2019
- Time:
- -
- Available Seats:
- 24
Over the last 20 years Australia has grown to become a destination of choice for the conduct of early phase clinical trials. Rapid ethics approval and a simple notification to the Therapeutic Goods Administrations (TGA) means that from submission to FPFD it will only take on average 6 weeks. Coupled with the attractive R&D tax incentive program offered by the Australian Government this swift to study data can then be used to support an IND or IMPD application allowing companies to speed up their drug development process
